PET/CT of cancer patients: Part 1, pancreatic neoplasms

Elizabeth H. Dibble, Dimitrios Karantanis, Gustavo Mercier, Patrick J. Peller, Lisa A. Kachnic, Rathan M. Subramaniam

Research output: Contribution to journalReview article

59 Scopus citations

Abstract

OBJECTIVE: Pancreatic cancer continues to have a poor prognosis despite impressive improvements in the outcomes of many other types of cancer, often because most pancreatic neoplasms are found to be unresectable at diagnosis. The purpose of this review is to provide an overview of pancreatic cancer and the role of modern imaging in its diagnosis and management with an emphasis on 18F-FDG PET/CT fusion imaging. CONCLUSION: Multimodality imaging is critical in the diagnosis and management of pancreatic cancer. PET/CT is increasingly viewed as a useful, accurate, and cost-effective modality in diagnosing and managing pancreatic cancer, but further studies are warranted. Early data suggest that contrast-enhanced PET/CT performed with modern PET/CT scanners yields high-resolution anatomic information for surgical and radiotherapeutic planning and functional information for whole-body staging in the care of patients with this disease.

Original languageEnglish (US)
Pages (from-to)952-967
Number of pages16
JournalAmerican Journal of Roentgenology
Volume199
Issue number5
DOIs
StatePublished - Nov 1 2012

Keywords

  • CT
  • MRI
  • PET/CT
  • Pancreatic cancer

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'PET/CT of cancer patients: Part 1, pancreatic neoplasms'. Together they form a unique fingerprint.

  • Cite this

    Dibble, E. H., Karantanis, D., Mercier, G., Peller, P. J., Kachnic, L. A., & Subramaniam, R. M. (2012). PET/CT of cancer patients: Part 1, pancreatic neoplasms. American Journal of Roentgenology, 199(5), 952-967. https://doi.org/10.2214/AJR.11.8182